Free shipping on orders over $149
SafeRxPills - Online Pharmacy
These products are intended for personal use only. We are not licensed by the FDA.
Back to BlogAntiparasitic

Albendazole Dosage for Adults and Children: Doses by Infection, Weight and Food

S

SafeRxPills Pharmacy Team

Editorial team at SafeRxPills. Articles are written and checked against regulatory drug labelling (DailyMed, FDA, EMA) and published literature.

May 18, 202622 min read
Last updated: October 26, 2026
Share:
In this article (23 sections)

The right albendazole dose depends on which parasite is being treated, how much the patient weighs and whether the drug needs to reach worms in the gut or cysts in the liver, lungs or brain. The US label covers only two tissue infections, neurocysticercosis and hydatid disease, and uses 400 mg twice daily with meals for adults weighing 60 kg or more. For common intestinal worms, the usual dose is a single 400 mg tablet, which comes from CDC guidance, the Indian Zentel label and WHO deworming programmes rather than from the US label.

This guide sets out each dose with its source, shows how the weight rule works below 60 kg, explains when to take albendazole with a fatty meal and when an empty stomach is advised, and lists the blood tests, side effects and pregnancy rules that come with longer courses. We sell albendazole 400 mg tablets made in India, so we have a commercial interest; every number below comes from the US prescribing information, the Indian Zentel prescribing information, CDC and WHO pages and a published study, all listed under Sources. Your prescriber decides your dose.

Albendazole dosage at a glance

UseDoseHow longSource
Neurocysticercosis, 60 kg or more400 mg twice daily with meals8 to 30 daysUS label
Hydatid disease, 60 kg or more400 mg twice daily with meals28-day cycle, 14 days off, 3 cycles in totalUS label
Either condition, under 60 kg15 mg/kg/day in two doses with meals, maximum 800 mg/dayAs aboveUS label
Pinworm, adults and children400 mg onceRepeat in two weeksCDC
Roundworm or hookworm400 mg onceSingle doseCDC
Whipworm400 mg once daily3 daysCDC
Deworming programmes for children400 mg once (200 mg under 24 months)Once or twice a yearWHO

Two things trip people up. First, "400 mg twice daily" in the US label means 800 mg a day, which in the US is four 200 mg tablets because the FDA has approved only a 200 mg albendazole tablet. Second, the food advice changes with the target: the US label says to take albendazole with food for tissue infections, while CDC's clinical guidance says to take the intestinal-worm doses on an empty stomach.

What the US label approves albendazole for

The current US prescribing information for albendazole tablets (Edenbridge version, effective July 2026) lists two indications:

  • Parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium.
  • Cystic hydatid disease of the liver, lung and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.

Pinworm, roundworm, hookworm and whipworm are not on the US label. CDC lists albendazole for them anyway and marks the roundworm, hookworm and whipworm entries as not FDA-approved for those infections. The Indian Zentel label, by contrast, includes the intestinal worms, cutaneous larva migrans, liver flukes and giardiasis in children, as well as cystic and alveolar echinococcosis and neurocysticercosis. The brand-name US product, Albenza, is listed as discontinued in the FDA's drug database, with a note that the FDA determined it was not withdrawn for safety or effectiveness reasons; generic 200 mg tablets from six makers are listed as prescription products. Our intestinal parasites page covers these worm infections and the medicines used for each.

If you want background on the brand, our Zentel (albendazole) guide covers what Zentel is and how it compares with other worm medicines. This page stays on dosing and safety.

Adult dose for neurocysticercosis and hydatid disease

Table 1 of the US label gives one dose for adults of 60 kg or more and a weight-based dose below that. The durations differ by condition.

ConditionWeightDoseDuration
Hydatid disease60 kg or more400 mg twice daily, with meals28-day cycle followed by a 14-day albendazole-free interval, for a total of 3 cycles
Hydatid diseaseUnder 60 kg15 mg/kg/day in two divided doses with meals (maximum 800 mg/day)Same cycles
Neurocysticercosis60 kg or more400 mg twice daily, with meals8 to 30 days
NeurocysticercosisUnder 60 kg15 mg/kg/day in two divided doses with meals (maximum 800 mg/day)8 to 30 days

For neurocysticercosis the label adds that patients should receive steroid and anticonvulsant therapy as required, and that oral or intravenous corticosteroids should be considered to prevent cerebral hypertensive episodes during the first week. That is because dying cysts inflame the surrounding brain tissue. These are specialist treatments planned after brain imaging, not courses to start from a pharmacy shelf.

Dosing by body weight under 60 kg

Below 60 kg the label switches to 15 mg per kg of body weight per day, split into two doses, with a ceiling of 800 mg a day. The table below applies that rule to sample weights. These are worked examples to show how the formula behaves, not a dosing tool: tablet sizes, rounding and the condition being treated all affect what a prescriber actually writes.

Body weight15 mg/kg/dayDaily dose after the 800 mg capEach of two doses
20 kg300 mg300 mg150 mg
30 kg450 mg450 mg225 mg
40 kg600 mg600 mg300 mg
50 kg750 mg750 mg375 mg
55 kg825 mg800 mg400 mg
60 kg or moreNot used800 mg400 mg
Bar chart of total daily albendazole dose computed from the US label rule of 15 mg/kg/day with a maximum of 800 mg/day: 20 kg 300 mg, 30 kg 450 mg, 40 kg 600 mg, 50 kg 750 mg, 55 kg 800 mg because the formula result of 825 mg is capped, and 60 kg or more 800 mg given as 400 mg twice daily.
Figure 1. Daily albendazole dose by body weight for hydatid disease and neurocysticercosis, computed from the US label rule (15 mg/kg/day in two doses, maximum 800 mg/day; 400 mg twice daily at 60 kg or more). From about 53.3 kg the formula already reaches the 800 mg cap. Your prescriber sets the actual dose. Source: US albendazole tablets label, section 2.1.

The cap means the weight rule and the adult dose meet at about 53.3 kg (15 times 53.3 is just under 800). Anyone above that weight ends up on 400 mg twice daily either way. The Indian Zentel label uses the same 15 mg/kg rule with the same 800 mg daily maximum for cystic echinococcosis, alveolar echinococcosis and neurocysticercosis.

How long a course lasts: cycles and drug-free gaps

Hydatid disease is treated in blocks. Under the US label, a patient takes albendazole daily for 28 days, stops for 14 days, then repeats, for three cycles in total. Counting the two breaks, a full course spans about 16 weeks (three 28-day cycles plus two 14-day gaps, 112 days).

The Indian Zentel label gives more detail by situation. For inoperable and multiple cysts, up to three 28-day cycles may be given for liver, lung and peritoneal cysts, and longer treatment may be needed for bone and brain. Before surgery, two 28-day cycles should be given where possible. After surgery, if the pre-operative course was short (under 14 days) or surgery was an emergency, two 28-day cycles separated by 14 drug-free days are advised. For alveolar echinococcosis, the same label notes that treatment may need to continue for months or years, and that continuous treatment at the same dose has been used for periods of up to 20 months.

Neurocysticercosis courses are shorter: 8 to 30 days in the US label, and 7 to 30 days in the Indian label depending on response, with a second course possible after a two-week gap.

Albendazole 400 mg for intestinal worms

Most people searching for an albendazole dose have an intestinal worm. Because the US label does not cover these infections, the doses below come from CDC clinical pages (checked 26 October 2026) and the Indian Zentel prescribing information (July 2026).

InfectionCDC doseIndian Zentel label dose
Pinworm (threadworm, enterobiasis)400 mg once, repeat in two weeks400 mg single dose (adults and children over 2)
Roundworm (ascariasis)400 mg once400 mg single dose
Hookworm400 mg once400 mg single dose
Whipworm (trichuriasis)400 mg once daily for 3 days400 mg single dose
Strongyloides, beef or pork tapeworm, dwarf tapewormNot covered here400 mg once daily for 3 consecutive days
Liver flukes (clonorchiasis, opisthorchiasis)Not covered here400 mg twice daily for 3 days
Cutaneous larva migransNot covered here400 mg once daily for 1 to 3 days
Giardiasis, children 2 to 12 onlyNot covered here400 mg once daily for 5 days

A few details matter. CDC repeats the pinworm dose after two weeks because the medicine kills worms but not eggs, so the second dose catches worms that hatched after the first. The Indian label says a second course is indicated if the patient is not cured after three weeks, and for proven dwarf tapeworm it recommends retreatment in 10 to 21 days. For whipworm, CDC's three-day course is longer than the Indian label's single dose. And the WHO fact sheet on soil-transmitted worms states that Strongyloides stercoralis is not sensitive to albendazole or mebendazole, so a positive Strongyloides test is a reason to ask your doctor which drug fits. Our intestinal worm treatment guide covers diagnosis and the other options.

The WHO single 400 mg dose, and why it is not a US label dose

WHO recommends albendazole 400 mg or mebendazole 500 mg as the medicines for large-scale treatment of soil-transmitted worms. WHO's eLENA deworming recommendation (page last updated 9 August 2023) recommends a single dose once or twice a year for children aged 12 to 23 months, 1 to 4 years and 5 to 12 years who live where at least 20% of children carry these worms, twice yearly where prevalence is above 50%, and a half dose of 200 mg for children younger than 24 months.

This is public health guidance for whole communities in endemic areas. It is not the same as treating one diagnosed person, and it is not part of the US label. The WHO fact sheet also counts women of reproductive age, including pregnant women in the second and third trimesters and breastfeeding women, among the groups at risk in these programmes.

Albendazole dose for children

The US label gives children the same weight-based rule as smaller adults for its two indications and states that, in neurocysticercosis, efficacy in children appears similar to that in adults. It notes that hydatid disease is uncommon in infants and young children.

For intestinal worms, the Indian Zentel label gives 400 mg as a single dose for children over 2 years and 200 mg as a single dose for children aged 1 to 2 years (pinworm, hookworm, roundworm and whipworm). For the long, high-dose courses used in tissue infections, the same label says experience in children under 6 is limited and use under 6 is not recommended. CDC states that the safety of albendazole in children under 6 is not certain, that studies in children as young as one year suggest it is safe, and that WHO campaigns have treated many children under six at a reduced dose.

Our mebendazole vs albendazole comparison covers which drug is usually picked for young children with pinworm. Our guide on how to treat pinworms also covers OTC pyrantel.

How to take albendazole tablets

  • Swallowing: the US label says the tablets may be crushed or chewed and swallowed with a drink of water. The Indian label says young children who find it hard to swallow should chew the tablet with a little water, or it can be crushed.
  • Chewable 400 mg tablets: Zentel 400 in India is an uncoated chewable tablet, so it is designed to be chewed before swallowing.
  • Timing: for tissue infections the label says twice daily with meals, so the two doses go with two of your daily meals. The half-life of the active metabolite is 8 to 12 hours in the US label, and peak levels arrive 2 to 5 hours after a dose.
  • Whole course: for hydatid disease, keep to the 28-day blocks and the 14-day breaks your prescriber sets, and attend the blood tests at each stage.

The US label does not give advice on missed doses. If you miss one, ask your pharmacist rather than doubling the next dose.

With food or on an empty stomach?

Albendazole dissolves poorly in water and is absorbed badly. The US label says bioavailability rises when it is taken with a fatty meal (about 40 g of fat), with plasma levels of the active metabolite, albendazole sulfoxide, up to 5-fold higher on average than in the fasted state. The Indian label gives the same figure, about five-fold, and states that less than 5% of an oral dose is absorbed.

Whether that extra absorption is wanted depends on where the parasite is:

SituationFood adviceSource
Hydatid disease, neurocysticercosisTake with mealsUS label, Indian label
Pinworm, roundworm, hookworm, whipwormTake on an empty stomachCDC
Intestinal infections (Indian label)No special procedures such as fasting or purging are requiredIndian Zentel label

The reasoning is that cysts in tissue are reached only by drug absorbed into the blood, while worms in the gut meet the drug inside the gut. A 1988 study in six patients with echinococcosis found mean blood levels and exposure 4.5 times higher when albendazole was taken with breakfast rather than fasting, and its authors suggested an empty stomach might suit intestinal parasites. The two sources for intestinal worms (CDC and the Indian label) do not say the same thing, so follow the instruction on your own prescription.

How much a fatty meal changes absorption

The kind of meal matters, not just whether you eat. In a 2021 crossover study, 12 healthy adults took a single 400 mg dose of two albendazole tablet brands after a low-fat breakfast (about 19% of calories from fat, 375 kcal) and after a high-fat breakfast (about 57% of calories from fat, 912 kcal).

Albendazole sulfoxide, meanLow-fat breakfastHigh-fat breakfast
Peak level, reference tablet830.0 ng/mL1,580.2 ng/mL
Peak level, test tablet860.6 ng/mL1,371.7 ng/mL
Exposure to 32 h (AUC), reference tablet8,125.4 ng·h/mL17,157.0 ng·h/mL
Exposure to 32 h (AUC), test tablet7,934.1 ng·h/mL14,781.2 ng·h/mL
Grouped bar chart of mean peak albendazole sulfoxide after a 400 mg dose. Reference tablet: 830 ng/mL with a low-fat breakfast and 1,580 ng/mL with a high-fat breakfast. Test tablet: 861 ng/mL low-fat and 1,372 ng/mL high-fat.
Figure 2. Fat in the meal matters, not just eating. The low-fat breakfast took about 19% of its calories from fat, the high-fat one about 57%. Total exposure (AUC to 32 hours) rose by 86% to 111%. Source: Ochoa 2021, Table 3, PMID 33935787.

Peak levels rose by 59% to 90% and total exposure by 86% to 111% with the high-fat breakfast. The two brands performed alike. The authors concluded that, since the label already says to take albendazole with meals, patients should be told to take it with a fatty meal so the treatment is not weakened. For comparison, the study's high-fat breakfast was an egg, sausage, French fries, whole milk, white bread and 30 g of oil; the low-fat one was white bread, whole milk and jam.

Blood and liver tests before and during treatment

Longer courses come with a fixed monitoring schedule in the US label:

TestWhenWhy
Blood countsAt the start of each 28-day cycle and every 2 weeks during therapyBone marrow suppression
Liver enzymes (transaminases)At the start of each cycle and at least every 2 weeksLiver enzyme rises, hepatitis
Pregnancy testBefore starting, in females who could become pregnantPossible fetal harm
Eye examination for retinal cystsBefore treating neurocysticercosisRetinal damage when cysts die
Check for hidden neurocysticercosisBefore treatment in people with risk factorsTreatment can uncover brain cysts

If liver enzymes exceed twice the upper limit of normal, the US label says stopping albendazole should be considered based on the patient's circumstances, and the Indian label says Zentel should be discontinued. Restarting after enzymes return to normal is an individual decision with more frequent tests. The US label also says to stop treatment if liver enzymes rise significantly or blood counts fall to a clinically significant degree. The US schedule is written around 28-day treatment cycles, and the Indian label sets its every-two-weeks liver and blood tests for systemic (longer, higher-dose) treatment.

Side effects in hydatid disease

The US label pools adverse reactions judged at least possibly related to albendazole and reports them separately for each disease, because the pattern differs. In hydatid disease, where patients take 28-day cycles, liver enzyme rises dominate.

Adverse reactionHydatid disease
Raised liver enzymes16%
Abdominal pain6%
Nausea4%
Vomiting4%
Reversible hair loss2%
Fever1%
Dizziness1%
Headache1%
Vertigo1%
Bar chart of adverse reactions in hydatid disease trials of albendazole: raised liver enzymes 16%, abdominal pain 6%, nausea 4%, vomiting 4%, reversible hair loss 2%, fever 1%, dizziness 1%, headache 1%, vertigo 1%.
Figure 3. Adverse reactions at 1% or more in hydatid disease, where treatment runs in 28-day cycles. Liver enzyme rises are the main finding; discontinuations for hepatic abnormalities: 3.8% in hydatid disease. Source: US albendazole tablets label, section 6.1, Table 2.

The label says these symptoms were usually mild and resolved without treatment. Discontinuations were mainly due to leukopenia (0.7%) or liver abnormalities (3.8% in hydatid disease). The liver enzyme rises have generally returned to normal after stopping.

Side effects in neurocysticercosis

Adverse reactionNeurocysticercosis
Headache11%
Nausea6%
Vomiting6%
Raised intracranial pressure2%
Meningeal signs1%
Raised liver enzymes, dizziness, vertigo, hair lossLess than 1% each
Bar chart of adverse reactions in neurocysticercosis trials of albendazole: headache 11%, nausea 6%, vomiting 6%, raised intracranial pressure 2%, meningeal signs 1%.
Figure 4. Adverse reactions at 1% or more in neurocysticercosis. Headache and raised brain pressure largely reflect inflammation as cysts in the brain die, which is why steroids and seizure medicine are given alongside. Source: US albendazole tablets label, section 6.1, Table 2.

Headache, raised pressure inside the skull and meningeal signs reflect the inflammatory reaction as parasites die in the brain. The label warns that seizures, raised intracranial pressure and focal signs can follow, which is why steroid and anticonvulsant cover is part of the regimen.

For single intestinal doses, the Indian label lists headache, dizziness, upper stomach symptoms (pain, nausea, vomiting) and diarrhoea as uncommon, and rash, itching, hives and liver enzyme rises as rare.

Rare but serious reactions

The US label opens its warnings with bone marrow suppression: deaths have been reported due to granulocytopenia or pancytopenia, and albendazole may cause bone marrow suppression, aplastic anemia and agranulocytosis. People with liver disease and those with hepatic echinococcosis are at higher risk and need more frequent blood counts. The drug should be stopped if blood counts fall to a clinically significant degree.

Other reactions reported after approval include hepatitis, acute liver failure, acute renal failure, rhabdomyolysis, convulsion, blurred vision, erythema multiforme and Stevens-Johnson syndrome. Because these come from voluntary reports, their frequency cannot be estimated.

Seek urgent care for fever with sore throat or mouth ulcers, unusual bruising or bleeding, yellowing of the skin or eyes, dark urine, a blistering or peeling rash, a seizure or a severe headache during treatment.

Who should not take albendazole

  • Allergy: the US label says albendazole is contraindicated in patients with known hypersensitivity to the benzimidazole class of compounds (which includes mebendazole) or any component of the tablet.
  • Pregnancy (Indian label): the Zentel label lists pregnancy and women thought to be pregnant as a contraindication: Zentel should not be administered during pregnancy.
  • Dye sensitivity: Zentel 400 tablets contain the colour sunset yellow FCF, which the Indian label says may cause allergic-type reactions.

Extra caution, not an outright ban, applies to people with liver disease or abnormal liver tests, low blood counts, people at risk of seizures from neurocysticercosis, or a chance of undiagnosed neurocysticercosis. In 5 patients with extrahepatic obstruction, peak levels doubled and exposure rose 7-fold, with a half-life of 31.7 hours.

Pregnancy, contraception and breastfeeding

The sources differ on detail, so here is each one in its own words:

SourcePregnancyContraception after the last dose
US label, generic albendazole (July 2026)May cause fetal harm based on animal studies; pregnancy testing recommended before startingEffective contraception during treatment and for 3 days after the final dose
Indian Zentel label (July 2026)Should not be administered during pregnancy or in women thought to be pregnantFor systemic infections, effective precautions during and within one month of completing treatment

Older US Albenza labelling advised birth control for one month after therapy; the current Edenbridge generic label (July 2026) shortened this to 3 days. The 2026 US label also notes that human data from published case series and studies of single doses later in pregnancy have not identified drug-associated risks for major birth defects or miscarriage, while animal studies in rats and rabbits showed embryotoxicity and skeletal malformations. For short intestinal courses, the Indian label advises women of childbearing age to start treatment during the first week of a period or after a negative pregnancy test.

On breastfeeding, the current US label says albendazole and its active metabolite have been reported at low concentrations in breast milk with no reports of harm to the breastfed infant. CDC notes that WHO has concluded a single oral dose can be given to breastfeeding women.

Drug interactions that change albendazole levels

MedicineEffect reportedSource
DexamethasoneTrough albendazole sulfoxide about 56% higherUS label
PraziquantelPeak level and AUC of albendazole sulfoxide about 50% higher (fed state)US label
CimetidineAbout 2-fold higher levels in bile and cyst fluidUS label
TheophyllineNo change after one 400 mg dose, but monitoring of theophylline levels recommendedUS label
Ritonavir, phenytoin, carbamazepine, phenobarbitalMay lower albendazole sulfoxide levels and reduce efficacyIndian Zentel label

The seizure medicines in the last row matter in neurocysticercosis, where anticonvulsants are often given at the same time; the Indian label says patients should be monitored for efficacy and may need other doses or therapies. The US label (section 12.3) also notes that after 4 weeks of 200 mg three times daily, levels in 12 patients were about 20% lower than in the first half of treatment, suggesting albendazole may speed up its own metabolism.

Liver, kidney and older patients

Albendazole is turned into its active form in the liver, so liver disease is the main dose-related concern. The Indian label says patients with abnormal liver tests before treatment should be carefully monitored, and the US label puts people with raised liver enzymes at higher risk of both liver injury and bone marrow suppression. For kidney disease, the US label says pharmacokinetics have not been studied, while the Indian label says no dose adjustment is required because renal elimination is negligible, with careful monitoring. Less than 1% of a dose is recovered in urine as albendazole sulfoxide. For people aged 65 and over, the Indian label finds no evidence that a different dose is needed, and data in 26 hydatid patients up to 79 years suggested similar drug handling to younger adults.

Albendazole tablets on SafeRxPills

We list two single-ingredient albendazole products, both 400 mg tablets made in India. Each tablet equals two US 200 mg tablets.

If your doctor prefers mebendazole, we also list Mebex 100mg (mebendazole) from Cipla. For US pack sizes, prices and availability, see our guide to buying Zentel albendazole in the USA.

Questions to ask your doctor or pharmacist

  • Which parasite was found, and is albendazole the best match for it?
  • Should I take my doses with a fatty meal or on an empty stomach?
  • How many tablets per dose, and for how many days or cycles?
  • When are my blood count and liver tests due?
  • Do I need a pregnancy test first, and how long should I use contraception afterwards?
  • Should my household be treated at the same time (for pinworm)?
  • Do any of my current medicines, especially seizure medicines or steroids, change the dose?

Sources

  1. Albendazole tablets USP 200 mg, US prescribing information, Edenbridge Pharmaceuticals, version 43, effective July 2026 (DailyMed setid 6c48fd89-cb40-477c-8a78-15cbe0df6faa): sections 1, 2.1 to 2.3, 4, 5.1 to 5.6, 6.1, 6.2, 7, 8.1 to 8.7, 12.3, 17.
  2. ALBENZA (albendazole) tablets, US prescribing information, Amneal, revised 09/2019 (DailyMed setid 1977a867-0ee1-44c0-8da3-fe59c48699f5): sections 5.2, 8.3 (earlier one-month contraception wording).
  3. ZENTEL (albendazole) 400 mg chewable tablets and oral suspension, Indian prescribing information, GlaxoSmithKline Pharmaceuticals Ltd, version ZEN/PI/IN/2026/01, revised 8 July 2026: sections 4.1 to 4.5, 4.8, 5.3.
  4. US Food and Drug Administration. Drugs@FDA via openFDA: NDA 020666 (Albenza, discontinued) and ANDAs 208094, 208979, 211034, 211117, 213435, 215652 (albendazole 200 mg tablets, Prescription status), accessed 26 October 2026.
  5. Centers for Disease Control and Prevention. Clinical Overview of Pinworm Infection, and Clinical Care of Soil-transmitted Helminths, accessed 26 October 2026.
  6. World Health Organization. Soil-transmitted helminth infections, fact sheet, 18 January 2023; and e-Library of Evidence for Nutrition Actions: Deworming in children, last updated 9 August 2023, both accessed 26 October 2026.
  7. Ochoa D, Saiz-Rodríguez M, González-Rojano E, et al. High-fat breakfast increases bioavailability of albendazole compared to low-fat breakfast: single-dose study in healthy subjects. Front Pharmacol 2021;12:664465. PMID 33935787.
  8. Lange H, Eggers R, Bircher J. Increased systemic availability of albendazole when taken with a fatty meal. Eur J Clin Pharmacol 1988;34:315-317. PMID 3396623.

This guide is for information and does not replace advice from a doctor or pharmacist who knows your medical history. Albendazole for tissue infections needs medical supervision with blood and liver tests.

?Frequently Asked Questions

What is the albendazole dose for adults?

It depends on the infection. For neurocysticercosis and hydatid disease, the US label gives 400 mg twice daily with meals for adults weighing 60 kg or more. For pinworm, roundworm and hookworm, CDC lists 400 mg once, with the pinworm dose repeated after two weeks, and 400 mg once daily for 3 days for whipworm.

How is albendazole dosed by weight?

Under 60 kg, the US label uses 15 mg per kg of body weight per day, split into two doses with meals, with a maximum of 800 mg a day. For example, the formula gives 450 mg a day at 30 kg and 750 mg a day at 50 kg. At about 53.3 kg and above, the result reaches the 800 mg cap.

Is one 400 mg albendazole tablet enough for worms?

For roundworm and hookworm, CDC and the Indian Zentel label both use a single 400 mg dose. Pinworm needs a second 400 mg dose two weeks later under CDC guidance because the drug does not kill eggs. Whipworm is treated for 3 days in CDC guidance, and tapeworm and Strongyloides for 3 days in the Indian label. WHO states Strongyloides is not sensitive to albendazole, so ask your doctor which drug fits a Strongyloides infection.

Should albendazole be taken with food?

For tissue infections such as hydatid disease and neurocysticercosis, yes: the US label says to take it with meals, and a fatty meal raises blood levels of the active metabolite up to 5-fold on average. For intestinal worms, CDC says to take the dose on an empty stomach, while the Indian Zentel label says no fasting is required. Follow the instruction on your prescription.

Can albendazole tablets be chewed or crushed?

Yes. The US label says the tablets may be crushed or chewed and swallowed with a drink of water. Zentel 400 sold in India is an uncoated chewable tablet, and its label suggests young children chew it with a little water or have it crushed.

What are the most common side effects of albendazole?

In hydatid disease trials, raised liver enzymes (16%), abdominal pain (6%), nausea and vomiting (4% each) and reversible hair loss (2%) were most common. In neurocysticercosis trials, headache (11%), nausea and vomiting (6% each) and raised intracranial pressure (2%) led the list. For single intestinal doses, the Indian Zentel label lists headache, dizziness and stomach upset as uncommon.

Why do I need blood tests while taking albendazole?

Albendazole can suppress the bone marrow, and deaths from very low blood cell counts have been reported. It can also raise liver enzymes. The US label asks for blood counts and liver enzymes at the start of each 28-day cycle and every 2 weeks during treatment, and a pregnancy test before starting in females who could become pregnant.

Can I take albendazole if I am pregnant?

The current US label says albendazole may cause fetal harm based on animal studies and recommends a pregnancy test before treatment and contraception for 3 days after the final dose. The Indian Zentel label is stricter: Zentel should not be administered during pregnancy or in women thought to be pregnant. Talk to your doctor before taking it if you are or may be pregnant.

How long does a course of albendazole last for hydatid disease?

The US label uses a 28-day course followed by a 14-day break, repeated for 3 cycles in total, which spans about 112 days. The Indian label allows up to three cycles for liver, lung and peritoneal cysts and longer treatment for bone and brain cysts or alveolar echinococcosis.

Which medicines interact with albendazole?

Dexamethasone, praziquantel and cimetidine raise levels of the active metabolite, by about 56%, about 50% and about 2-fold (in bile and cyst fluid) respectively, according to the US label. The Indian Zentel label says ritonavir, phenytoin, carbamazepine and phenobarbital may lower levels and reduce efficacy. The US label also recommends monitoring theophylline levels.

What dose of albendazole do children take?

For intestinal worms, the Indian Zentel label gives 400 mg once for children over 2 years and 200 mg once for children aged 1 to 2 years, and WHO uses a 200 mg half dose under 24 months in deworming programmes. For tissue infections the US label uses 15 mg/kg/day in two doses, and the Indian label does not recommend long high-dose courses under age 6.

S

SafeRxPills Pharmacy Team

SafeRxPills Editorial Team

Editorial team at SafeRxPills. Articles are written and checked against regulatory drug labelling (DailyMed, FDA, EMA) and published literature.

Comments (0)

Leave a Comment

No comments yet. Be the first to share your thoughts!